|Mr. Thomas C. Chesterman M.B.A.||Exec. VP, CFO, Treasurer & Assistant Sec.||279.28k||N/A||1959|
|Dr. Steven C. Krause Ph.D.||Exec. VP of Sales & Marketing||212.5k||N/A||1960|
|Mr. Kenneth S. Siegel||Exec. Director||329.94k||N/A||1956|
|Mr. Joel Fruendt||CEO & Director||N/A||N/A||1961|
|Ms. Kim Patrice Wolin||Exec. VP of Operations & Sec.||N/A||N/A||1955|
|Ms. Nicole Williams||Chief Strategy Officer||N/A||N/A||1980|
|Mr. Paul M. Palz||VP & Corp. Controller||N/A||N/A||N/A|
|Robert Blum||Investor Relations||N/A||N/A||N/A|
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.